Kleo Pharmaceuticals, Inc.
Records under this name other than the patents Kleo Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 7 of 7 · Back to Kleo Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,572,370 | CD16A Binding Agents and Uses Thereof now held by Biohaven Therapeutics Ltd. In force · High confidence | In force | High confidence | |
| US 12,491,246 | Combination Therapy of Arms and Natural Killer Cells now held by Biohaven Therapeutics Ltd. In force · High confidence | In force | High confidence | |
| US 12,773,458 | Directed Conjugation Technologies now held by Biohaven Therapeutics Ltd. In force · High confidence | In force | High confidence | |
| 16/634,032 | Universal Abt Compounds and Uses Thereof held by Biohaven Therapeutics Ltd. Abandoned Abandoned Jul 6, 2026 | Abandoned | Abandoned Jul 6, 2026 | |
| 18/909,629 | CD16A Binding Agents and Uses Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/350,513 | Combination Therapy of Arms and Natural Killer Cells Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/677,891 | Universal Abt Compounds and Uses Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |